Human glycogen debranching enzyme gene (AGL): Complete structural organization and characterization of the 5' flanking region

Yong Bao, Thomas L. Dawson, Yuan Tsong Chen

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Glycogen debranching enzyme (gene symbol, AGL) is a multifunctional enzyme acting as 1, 4-α-D-glucan:1, 4-α-D-glucan 4-α-D- glycosyltransferase and amylo-1, 6-glucosidase in glycogen degradation. Genetic deficiency of AGL activity causes glycogen storage disease type III (GSD-III). To determine the molecular basis of GSD-III and elucidate the mechanisms for controlling tissue-specific gene expression, we report the isolation and structural organization of the human chromosomal AGL gene. The gene is 85 kb in length and is composed of 35 exons, encoding a 7.0-kb mRNA. The first 2 exons and 68 bp of exon 3 contain 5' untranslated region. Translation begins in exon 3, which encodes the first 27 amino acids of the AGL. Exons 4 to 35 encode the remaining 1505 amino acids. Among the 6 isoforms identified, the major isoform (isoform 1) starts with exon 1 and is widely expressed, including expression in both liver and muscle. Muscle- specific isoforms (2, 3, and 4) begin with exon 2. Isoforms 5 and 6 are minor isoforms that begin further within the gene. Reporter assays revealed that promoter region 1 (for isoform 1) was functional in liver (HepG2 cells), muscle (C2C12 cells), and ovary (Chinese hamster ovary cells), and promoter region 2 (for muscle-specific isoforms) was active only in muscle. These results suggest that the human AGL gene contains at least 2 promoter regions that confer differential expression of isoform mRNAs in a tissue- specific manner.

Original languageEnglish
Pages (from-to)155-165
Number of pages11
JournalGenomics
Volume38
Issue number2
DOIs
StatePublished - Dec 1 1996
Externally publishedYes

Fingerprint

Glycogen Debranching Enzyme System
5' Flanking Region
Protein Isoforms
Exons
Genes
Glycogen Storage Disease Type III
Genetic Promoter Regions
Muscles
amylo-1,6-glucosidase
Ovary
Multifunctional Enzymes
RNA Isoforms
Amino Acids
Glycosyltransferases
5' Untranslated Regions
Liver
Hep G2 Cells
Cricetulus
Glycogen
Muscle Cells

ASJC Scopus subject areas

  • Genetics

Cite this

Human glycogen debranching enzyme gene (AGL) : Complete structural organization and characterization of the 5' flanking region. / Bao, Yong; Dawson, Thomas L.; Chen, Yuan Tsong.

In: Genomics, Vol. 38, No. 2, 01.12.1996, p. 155-165.

Research output: Contribution to journalArticle

@article{8711ef3fd96e4a48bf35b71d60447888,
title = "Human glycogen debranching enzyme gene (AGL): Complete structural organization and characterization of the 5' flanking region",
abstract = "Glycogen debranching enzyme (gene symbol, AGL) is a multifunctional enzyme acting as 1, 4-α-D-glucan:1, 4-α-D-glucan 4-α-D- glycosyltransferase and amylo-1, 6-glucosidase in glycogen degradation. Genetic deficiency of AGL activity causes glycogen storage disease type III (GSD-III). To determine the molecular basis of GSD-III and elucidate the mechanisms for controlling tissue-specific gene expression, we report the isolation and structural organization of the human chromosomal AGL gene. The gene is 85 kb in length and is composed of 35 exons, encoding a 7.0-kb mRNA. The first 2 exons and 68 bp of exon 3 contain 5' untranslated region. Translation begins in exon 3, which encodes the first 27 amino acids of the AGL. Exons 4 to 35 encode the remaining 1505 amino acids. Among the 6 isoforms identified, the major isoform (isoform 1) starts with exon 1 and is widely expressed, including expression in both liver and muscle. Muscle- specific isoforms (2, 3, and 4) begin with exon 2. Isoforms 5 and 6 are minor isoforms that begin further within the gene. Reporter assays revealed that promoter region 1 (for isoform 1) was functional in liver (HepG2 cells), muscle (C2C12 cells), and ovary (Chinese hamster ovary cells), and promoter region 2 (for muscle-specific isoforms) was active only in muscle. These results suggest that the human AGL gene contains at least 2 promoter regions that confer differential expression of isoform mRNAs in a tissue- specific manner.",
author = "Yong Bao and Dawson, {Thomas L.} and Chen, {Yuan Tsong}",
year = "1996",
month = "12",
day = "1",
doi = "10.1006/geno.1996.0611",
language = "English",
volume = "38",
pages = "155--165",
journal = "Genomics",
issn = "0888-7543",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Human glycogen debranching enzyme gene (AGL)

T2 - Complete structural organization and characterization of the 5' flanking region

AU - Bao, Yong

AU - Dawson, Thomas L.

AU - Chen, Yuan Tsong

PY - 1996/12/1

Y1 - 1996/12/1

N2 - Glycogen debranching enzyme (gene symbol, AGL) is a multifunctional enzyme acting as 1, 4-α-D-glucan:1, 4-α-D-glucan 4-α-D- glycosyltransferase and amylo-1, 6-glucosidase in glycogen degradation. Genetic deficiency of AGL activity causes glycogen storage disease type III (GSD-III). To determine the molecular basis of GSD-III and elucidate the mechanisms for controlling tissue-specific gene expression, we report the isolation and structural organization of the human chromosomal AGL gene. The gene is 85 kb in length and is composed of 35 exons, encoding a 7.0-kb mRNA. The first 2 exons and 68 bp of exon 3 contain 5' untranslated region. Translation begins in exon 3, which encodes the first 27 amino acids of the AGL. Exons 4 to 35 encode the remaining 1505 amino acids. Among the 6 isoforms identified, the major isoform (isoform 1) starts with exon 1 and is widely expressed, including expression in both liver and muscle. Muscle- specific isoforms (2, 3, and 4) begin with exon 2. Isoforms 5 and 6 are minor isoforms that begin further within the gene. Reporter assays revealed that promoter region 1 (for isoform 1) was functional in liver (HepG2 cells), muscle (C2C12 cells), and ovary (Chinese hamster ovary cells), and promoter region 2 (for muscle-specific isoforms) was active only in muscle. These results suggest that the human AGL gene contains at least 2 promoter regions that confer differential expression of isoform mRNAs in a tissue- specific manner.

AB - Glycogen debranching enzyme (gene symbol, AGL) is a multifunctional enzyme acting as 1, 4-α-D-glucan:1, 4-α-D-glucan 4-α-D- glycosyltransferase and amylo-1, 6-glucosidase in glycogen degradation. Genetic deficiency of AGL activity causes glycogen storage disease type III (GSD-III). To determine the molecular basis of GSD-III and elucidate the mechanisms for controlling tissue-specific gene expression, we report the isolation and structural organization of the human chromosomal AGL gene. The gene is 85 kb in length and is composed of 35 exons, encoding a 7.0-kb mRNA. The first 2 exons and 68 bp of exon 3 contain 5' untranslated region. Translation begins in exon 3, which encodes the first 27 amino acids of the AGL. Exons 4 to 35 encode the remaining 1505 amino acids. Among the 6 isoforms identified, the major isoform (isoform 1) starts with exon 1 and is widely expressed, including expression in both liver and muscle. Muscle- specific isoforms (2, 3, and 4) begin with exon 2. Isoforms 5 and 6 are minor isoforms that begin further within the gene. Reporter assays revealed that promoter region 1 (for isoform 1) was functional in liver (HepG2 cells), muscle (C2C12 cells), and ovary (Chinese hamster ovary cells), and promoter region 2 (for muscle-specific isoforms) was active only in muscle. These results suggest that the human AGL gene contains at least 2 promoter regions that confer differential expression of isoform mRNAs in a tissue- specific manner.

UR - http://www.scopus.com/inward/record.url?scp=0030447828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030447828&partnerID=8YFLogxK

U2 - 10.1006/geno.1996.0611

DO - 10.1006/geno.1996.0611

M3 - Article

C2 - 8954797

AN - SCOPUS:0030447828

VL - 38

SP - 155

EP - 165

JO - Genomics

JF - Genomics

SN - 0888-7543

IS - 2

ER -